Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Does COPD affect bone mineral content?].

C Hens1, W Böhning

  • 1Karl-Hansen-Klinik, Bad Lippspringe.

Pneumologie (Stuttgart, Germany)
|February 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endowing networks with desired symmetries and modular behavior.

Physical review. E·2023
Same author

Comparison of normal distribution-based and nonparametric decision limits on the GH-2000 score for detecting growth hormone misuse (doping) in sport.

Biometrical journal. Biometrische Zeitschrift·2020
Same author

Engineering generalized synchronization in chaotic oscillators.

Chaos (Woodbury, N.Y.)·2011
Same author

Comparability of pulse oximeters used in sleep medicine for the screening of OSA.

Physiological measurement·2010
Same author

Fenoterol hydrobromide delivered via HFA-MDI or CFC-MDI in patients with asthma: a safety and efficacy comparison.

Respiratory medicine·2000
Same author

[Requirements for product quality of theophylline sustained-release preparations].

Arzneimittel-Forschung·1998
Same journal

Pneumologie (Stuttgart, Germany)·2026
Same journal

Aerosol therapy during noninvasive ventilation (NIV) and nasal high-flow therapy (HFT): current technology and consensus-based recommendations.

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Correction: Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Erratum: Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Acute lung failure].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[The internet as a source of information for patients with sarcoidosis].

Pneumologie (Stuttgart, Germany)·2026
See all related articles

This study found that steroid treatment in Chronic Obstructive Pulmonary Disease (COPD) patients is linked to lower bone mineral content (BMC). Severity of airway obstruction also correlates with decreased BMC in both treated and untreated COPD patients.

Area of Science:

  • Bone Densitometry
  • Pulmonary Medicine
  • Endocrinology

Context:

  • Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease.
  • Corticosteroid therapy is common in COPD management but may have side effects.
  • Bone mineral content (BMC) is a key indicator of bone health.

Purpose:

  • To investigate the relationship between steroid therapy, COPD severity, and bone mineral content (BMC).
  • To compare BMC levels in steroid-treated COPD patients, steroid-free COPD patients, and healthy controls.

Summary:

  • A retrospective study compared 85 steroid-free COPD patients, 78 steroid-treated COPD patients, and 126 healthy controls.
  • Bone mineral content (BMC) was measured in the lumbar spine and femur neck using two-photon absorption.

Related Experiment Videos

  • Results indicate significantly lower BMC in steroid-treated patients compared to both steroid-free patients and controls.
  • Lower BMC was also observed in women compared to men.
  • A significant correlation was found between the severity of airway obstruction and decreased BMC in both steroid-treated and steroid-free COPD patients.

    • Impact:

    • Highlights the potential negative impact of corticosteroid therapy on bone health in COPD patients.
    • Underscores the need for monitoring bone density in COPD patients, particularly those on steroid treatment.
    • Suggests that airway obstruction severity is an independent risk factor for reduced bone mineral content in COPD.